It is worth mentioning that EGFR and GD2 are reported to be expressed on many other tumors beside GBM, such as melanoma and neuroblastoma, and therefore, our approach can be extended in the future to target such tumors (32, 71, 72). This evidence concerns the gene EGFR and melanoma.